References
- Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 2000;15:412–426.
- Cahill GF, Veech RL. Ketoacids? Good medicine? Trans Am Clin Climatol Assoc. 2003;114:149.
- VanItallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutr Rev. 2003;61:327–41.
- Savage M, Dhatariya K, Kilvert A, Rayman G, Rees JA, Courtney CH, et al.. Joint British diabetes societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28:508–15.
- Nehlig A. Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot Essent Fatty Acids. 2004;70:265–75.
- Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000;105:e46–6.
- Levy RG, Cooper PN, Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2012;3:CD001903
- Henderson ST. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics. 2008;5:470–80.
- Testai FD, Aiyagari V. Acute hemorrhagic stroke pathophysiology and medical interventions: blood pressure control, management of anticoagulant-associated brain hemorrhage and general management principles. Neurol Clin. 2008;26:963–85.
- Sivenius J, Skvortsova V, Wardlaw J. Guidelines for management of ischemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457–507.
- Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, et al.. Recommendations for the management of intracranial haemorrhage – part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the eusi executive committee. Cerebrovasc Dis. 2006;22:294.
- Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660.
- Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke scale certification is reliable across multiple venues. Stroke. 2009;40:2507–11.
- Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19:1497–500.
- Janssen MJ, Hendrickx BH, Habets-van der Poel CD, van den Bergh JP, Haagen AA, Bakker JA. Accuracy of the precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sample. Clin Chem Lab Med. 2010;48:1781–4.
- Voulgari C, Tentolouris N. The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room. Diabetes Technol Ther. 2010;12:529–35.
- Kirsch J, d'Alecy L. Hypoxia induced preferential ketone utilization by rat brain slices. Stroke. 1984;15:319–23.
- Škrha J, Kunešová M, Hilgertova J, et al.. Short-term very low calorie diet reduces oxidative stress in obese type 2 diabetic patients. Physiol Res. 2005;54:33–9.
- Avogaro A, Crepaldi C, Miola M, Maran A, Pengo V, Tiengo A, et al.. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. J Endocrinol Invest. 1996;19:99.
- Suzuki M, Suzuki M, Sato K, et al.. Effect of. Beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol. 2001;87:143–50.
- Fuentes B, Ortega-Casarrubios MA, SanJosé B, Castillo J, Leira R, Serena J, et al.. Persistent hyperglycemia >155 mg/dl in acute ischemic stroke patients: how well are we correcting it? Implications for outcome. Stroke. 2010;41:2362–5.